Prenatal exposures to perfluoroalkyl acids and serum lipids at ages 7 and 15 in females

Environment International

Volumn 82, Issue , 2015, Pages 49-60

  Maisonet, Mildred ^a,b   Näyhä, Simo ^b   Lawlor, Debbie A ^c   Marcus, Michele ^d  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d EMORY UNIVERSITY   (United States)

Author keywords

ALSPAC; Endocrine disruption; Fetal origins of adult disease; Lipid metabolism; Perfluoroalkyl acids; PFOA; PFOS

Indexed keywords

CHOLESTEROL; METABOLISM; PIECEWISE LINEAR TECHNIQUES;

ALSPAC; ENDOCRINE DISRUPTION; LIPID METABOLISMS; PERFLUOROALKYL ACIDS; PFOA; PFOS;

LIPIDS;

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; TRIACYLGLYCEROL; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE;

CHILD HEALTH; CONCENTRATION (COMPOSITION); DISEASE INCIDENCE; ENDOCRINE DISRUPTOR; HEALTH IMPACT; LIPID; METABOLISM; ORGANOCHLORINE; POLLUTION EXPOSURE; PREGNANCY; SERUM; WOMENS HEALTH;

ADOLESCENCE; ADOLESCENT; ARTICLE; CHEMICAL ANALYSIS; CHILD; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; DAUGHTER; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; BLOOD; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; PREGNANCY; STATISTICAL MODEL;

ADOLESCENT; ADULT; ALKANESULFONIC ACIDS; CAPRYLATES; CHILD; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; FLUOROCARBONS; HUMANS; LINEAR MODELS; LIPIDS; LONGITUDINAL STUDIES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TRIGLYCERIDES;

EID: 84929650647     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2015.05.001     Document Type: Article

References (32)

1. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 2007, 115:1670-1676.
2. Avon Longitudinal Study of Parents and Children (accessed 31 July 2014). http://www.bristol.ac.uk/alspac/.
3. Barker D.J.P. Fetal nutrition and cardiovascular disease in later life. Br. Med. Bull. 1997, 53:96-108.
4. Boyd A., Golding J., Macleod J., Lawlor D.A., Fraser A., Henderson J., et al. Cohort profile: the 'children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 2013, 42:111-127.
5. Christensen K.Y., Maisonet M., Rubin C., Holmes A., Calafat A.M., Kato K., et al. Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort. Environ. Int. 2011, 37:129-135.
6. Dai S., Fulton J.E., Harrist R.B., Grunbaum J.A., Steffen L.M., Labarthe D.R. Blood lipids in children: age-related patterns and association with body-fat indices: Project HeartBeat!. Am. J. Prev. Med. 2009, 37:s56-s64.
7. Eriksen K.T., Raaschou-Nielsen O., McLaughlin J.K., Lipworth L., Tjønneland A., Overvad K., et al. Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population. PLoS One 2013, 8:e56969.
8. Eschauzier C., Raat K.J., Stuyfzand P.J., De Voogt P. Perfluorinated alkylated acids in groundwater and drinking water: identification, origin and mobility. Sci. Total Environ. 2013, 458-60:477-485.
9. Fraser A., Macdonald-Wallis C., Tilling K., Boyd A., Golding J., Davey Smith G., et al. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int. J. Epidemiol. 2013, 42:97-110.
10. Frisbee S.J., Shankar A., Knox S.S., Steenland K., Savitz D.A., Fletcher T., et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch. Pediatr. Adolesc. Med. 2010, 164:860-869.
11. Geiger S.D., Xiao J., Ducatman A., Frisbee S., Innes K., Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere 2014, 98:78-83.
12. Halldorsson T.I., Rytter D., Haug L.S., Bech B.H., Danielsen I., Becher G., Henriksen T.B., Olsen S.F. Prenatal exposure to perfluorooctanoate and risk of overweight at 20years of age: a prospective cohort study. Environ. Health Perspect. 2012, 120:668-673.
13. Howe L.D., Lawlor D.A., Propper C. Trajectories of socioeconomic inequalities in health, behaviours and academic achievement across childhood and adolescence. J. Epidemiol. Community Health 2013, 67:358-364.
14. Joensen U.N., Veyrand B., Antignac J.P., Blomberg Jensen M., Petersen J.H., Marchand P., et al. PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. Hum. Reprod. 2013, 28:599-608.
15. Johnson P.I., Sutton P., Atchley D.S., Koustas E., Lam J., Sen S., Robinson K.A., Axelrad D.A., Woodruff T.J. The navigation guide-evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 2014, 122:1028-1039.
16. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ. Sci. Technol. 2011, 45:8037-8045.
17. Knobeloch L., Imm P., Anderson H. Perfluoroalkyl chemicals in vacuum cleaner dust from 39 Wisconsin homes. Chemosphere 2012, 88:779-783.
18. Kuklenyik Z., Needham L.L., Calafat A.M. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal. Chem. 2005, 77:6085-6091.
19. Lauer R.M., Lee J., Clarke W.R. Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics 1988, 82:309-318.
20. Lindstrom A.B., Strynar M.J., Libelo E.L. Polyfluorinated compounds: past, present, and future. Environ. Sci. Technol. 2011, 45:7954-7961.
21. Loveless S.E., Finlay C., Everds N.E., Frame S.R., Gillies P.J., O'Connor J.C., et al. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 2006, 220:203-217.
22. Nelson J.W., Hatch E.E., Webster T.F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ. Health Perspect. 2010, 118:197-202.
23. Noorlander C.W., van Leeuwen S.P., Te Biesebeek J.D., Mengelers M.J., Zeilmaker M.J. Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands. J. Agric. Food Chem. 2011, 59:7496-7505.
24. Qazi M.R., Abedi M.R., Nelson B.D., DePierre J.W., Abedi-Valugerdi M. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. Int. Immunopharmacol. 2010, 10:1420-1427.
25. Ricote M., Glass C.K. New roles for PPARs in cholesterol homeostasis. Trends Pharmacol. Sci. 2001, 22:441-443.
26. Rosen M.B., Thibodeaux J.R., Wood C.R., Zehr R.D., Schmid J.E., Lau C. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology 2007, 239:15-33.
27. Starling A.P., Engel S.M., Whitworth K.W., Richardson D.B., Stuebe A.M., Daniels J.L., et al. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study. Environ. Int. 2014, 62:104-112.
28. Steenland K., Tinker S., Frisbee S., Ducatman A., Vaccarino V. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am. J. Epidemiol. 2009, 170:1268-1278.
29. Stein C.R., Wolff M.S., Calafat A.M., Kato K., Engel S.M. Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study. Reprod. Toxicol. 2012, 34:312-316.
30. Stockholm Convention (accessed 30 August 2014). http://chm.pops.int/Home/tabid/2121/mctl/ViewDetails/EventModID/871/EventID/514/xmid/6921/Default.aspx.
31. Vestergren R., Cousins I.T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ. Sci. Technol. 2009, 43:5565-5575.
32. Wolf C.J., Takacs M.L., Schmid J.E., Lau C., Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol. Sci. 2008, 106:162-171.